Toxic medications in Leber's hereditary optic neuropathy.
Antimicrobials
Leber's hereditary optic neuropathy
Medications
Mitochondrial toxicity
Journal
Mitochondrion
ISSN: 1872-8278
Titre abrégé: Mitochondrion
Pays: Netherlands
ID NLM: 100968751
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
14
03
2018
revised:
23
05
2018
accepted:
31
07
2018
pubmed:
7
8
2018
medline:
17
8
2019
entrez:
7
8
2018
Statut:
ppublish
Résumé
Leber's hereditary optic neuropathy (LHON) is a maternally inherited mitochondrial disorder characterized by acute bilateral vision loss. The pathophysiology involves reactive oxygen species (ROS), which can be affected by medications. This article reviews the evidence for medications with demonstrated and theoretical effects on mitochondrial function, specifically in relation to increased ROS production. The data reviewed provides guidance when selecting medications for individuals with LHON mutations (carriers) and are susceptible to conversion to affected. However, as with all medications, the proven benefits of these therapies must be weighed against, in some cases, purely theoretical risks for this unique patient population.
Identifiants
pubmed: 30081212
pii: S1567-7249(18)30036-9
doi: 10.1016/j.mito.2018.07.007
pii:
doi:
Substances chimiques
Reactive Oxygen Species
0
Types de publication
Journal Article
Review
Langues
eng
Pagination
270-277Informations de copyright
Copyright © 2018 Elsevier B.V. and Mitochondria Research Society. All rights reserved.